Quick Answer
Harmony Biosciences Holdings, Inc. reported Net Income of $158.69 million for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $158.69M | +9.1% |
| 2024 | $145.49M | +12.9% |
| 2023 | $128.85M | -29.0% |
| 2022 | $181.47M | +424.5% |
| 2021 | $34.60M | +193.6% |
| 2020 | -$36.94M | +75.7% |
| 2019 | -$151.98M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $50.87M | +10.4% | +27.9% |
| June 30, 2025 | $39.78M | +243.2% | -12.7% |
| March 31, 2025 | $45.56M | +18.9% | -1.2% |
| September 30, 2024 | $46.09M | +19.8% | +297.7% |
| June 30, 2024 | $11.59M | -66.2% | -69.8% |
| March 31, 2024 | $38.33M | +30.0% | -0.3% |
| September 30, 2023 | $38.46M | -56.3% | +12.1% |
| June 30, 2023 | $34.30M | +45.8% | +16.3% |
- Harmony Biosciences Holdings, Inc. showed an increase of +9.1% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Harmony Biosciences Holdings, Inc.’s net income has grown by 204.4% (from -$151.98 million to $158.69 million).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: